Of note, multivariate analysis indicated that high expression levels of P4HA2 p=0.037, HR=1.825) were significantly associated with worse prognosis in cervical cancer patients independently of advanced FIGO stage (p=0.024, HR=2.307) and lymph node metastasis (p=0.000, HR=2.611). Here, P4HA2 is linked to cervical cancer.